COQ8A (Q8NI60) variants and mutations
COQ8A (also known as Q8NI60) is a human protein-coding gene encoding an atypical kinase COQ8A, mitochondrial protein. It supports coenzyme Q biosynthesis and mitochondrial respiratory function, particularly in neurons and cerebellar tissue. Biallelic pathogenic variants cause primary coenzyme Q10 deficiency with cerebellar ataxia and variable seizures, neuropathy, or developmental impairment. This analysis covers 1,263 COQ8A variants and mutations. Of these, 77% have computational variant effect predictions. Disease context includes autosomal recessive ataxia due to ubiquinone deficiency, coenzyme Q10 deficiency, and coenzyme Q10 deficiency, primary, 1. Example COQ8A variants include A2D, A2P, and A2S.
Variant analysis overview
- Gene: COQ8A
- Protein: Q8NI60
- UniProt accession: Q8NI60
- Organism: Homo sapiens
- Variants analyzed: 1263
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 1,017 unspecified-consequence records; 111 missense variants; 102 synonymous variants; 17 frameshift variants; 7 stop-gained variants; 3 splice-region variants; 2 in-frame deletions; 4 substitution
- Prediction scores: 977 variants have prediction scores (77% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: autosomal recessive ataxia due to ubiquinone deficiency, coenzyme Q10 deficiency, coenzyme Q10 deficiency, primary, 1, hereditary disease, cataract, Abnormality of the skeletal system, mitochondrial disease, migraine disorder, cerebellar ataxia, mathematical ability, Abnormality of the nervous system, Cerebellar atrophy.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 1 domains; 5 binding sites.
- Structural context: 337 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable COQ8A variants
Examples include A2D, A2P, A2S, A3V, A3G, A3A, I4K, I4M. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2D (p.Ala2Asp), cosmic curated COSV64657
- A2P (p.Ala2Pro), ExAC rs749147197, gnomAD rs749147197, REVEL 0.31, CADD 21.70
- A2S (p.Ala2Ser), gnomAD 1-226961389-G-T, REVEL 0.15, CADD 16.40
- A3V (p.Ala3Val), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10082, Variant assessed as somatic; moderate impact.
- A3G (p.Ala3Gly), gnomAD 1-226961393-C-G, REVEL 0.18, CADD 19.50
- A3A (p.Ala3Ala), gnomAD 1-226961394-C-T, CADD 7.36
- I4K (p.Ile4Lys), rs202075418, ClinGen CA324879, ClinVar RCV000200326, ESP rs202075418, REVEL 0.29, CADD 22.80, Uncertain significance, not provided
- I4M (p.Ile4Met), Ensembl rs999819239, REVEL 0.14, CADD 3.72
- I4V (p.Ile4Val), rs372487479, ClinGen CA1424905, ClinVar RCV002800415, ESP rs372487479, REVEL 0.16, CADD 15.10, Uncertain significance, not provided
- L5F (p.Leu5Phe), cosmic curated COSV10592
- L5L (p.Leu5Leu), rs564251019, gnomAD 1-226961398-T-C, CADD 1.32
- D7G (p.Asp7Gly), ExAC rs771781610, TOPMed rs771781610, gnomAD rs771781610, REVEL 0.76, CADD 25.20
- D7Y (p.Asp7Tyr), NCI-TCGA Cosmic COSV6465, cosmic curated COSV64656, Variant assessed as somatic; moderate impact.
- D7D (p.Asp7Asp), rs1281163330, gnomAD 1-226961406-C-T, CADD 0.66
- T8A (p.Thr8Ala), TOPMed rs1466683362, gnomAD rs1466683362, REVEL 0.15, CADD 2.00
- T8I (p.Thr8Ile), gnomAD 1-226961408-C-T, REVEL 0.17, CADD 16.40
- T8N (p.Thr8Asn), gnomAD 1-226961408-C-A, REVEL 0.13, CADD 20.20
- I9V (p.Ile9Val), rs529609184, ClinGen CA1424908, ClinVar RCV002178126, 1000Genomes rs529609184, REVEL 0.15, CADD 14.90, Conflicting interpretations, not provided
- I9T (p.Ile9Thr), gnomAD 1-226961411-T-C, REVEL 0.40, CADD 23.20
- I9I (p.Ile9Ile), rs1280718957, gnomAD 1-226961412-C-T, CADD 8.67
- M10L (p.Met10Leu), 1000Genomes rs539885861, REVEL 0.22, CADD 17.50
- M10T (p.Met10Thr), ExAC rs760217137, gnomAD rs760217137
- M10I (p.Met10Ile), gnomAD 1-226961414-TGGTG, CADD 32.00
- V11W (p.Val11Trp), gnomAD 1-226961414-TG-T, CADD 32.00
- V11A (p.Val11Ala), gnomAD 1-226961417-T-C, REVEL 0.38, CADD 23.50
- A12S (p.Ala12Ser), ExAC rs770546950, gnomAD rs770546950, REVEL 0.05, CADD 20.80
- A12V (p.Ala12Val), ExAC rs200052870, TOPMed rs200052870, gnomAD rs200052870, REVEL 0.07, CADD 16.40
- A12D (p.Ala12Asp), gnomAD 1-226961420-C-A, REVEL 0.23, CADD 22.50
- A12A (p.Ala12Ala), rs763370071, gnomAD 1-226961421-T-C, CADD 10.20
- K13E (p.Lys13Glu), ExAC rs764577827, gnomAD rs764577827, REVEL 0.34, CADD 23.50
- K13R (p.Lys13Arg), gnomAD 1-226961421-TAA-T, CADD 31.00
- G14A (p.Gly14Ala), Ensembl rs567681518, REVEL 0.67, CADD 25.90
- G14D (p.Gly14Asp), gnomAD 1-226961426-G-A, REVEL 0.82, CADD 26.30
- V16I (p.Val16Ile), NCI-TCGA Cosmic COSV6465, TOPMed rs1658245367, gnomAD rs1658245367, REVEL 0.08, CADD 21.70, Variant assessed as somatic; moderate impact.
- V16L (p.Val16Leu), cosmic curated COSV64659
- V16F (p.Val16Phe), gnomAD 1-226961431-G-T, REVEL 0.10, CADD 22.50
- K17Q (p.Lys17Gln), TOPMed rs1658245506
- K17R (p.Lys17Arg), rs150221608, ClinGen CA38625628, ClinVar RCV000516337, ESP rs150221608, REVEL 0.19, CADD 21.40, Uncertain significance, not specified
- K17T (p.Lys17Thr), gnomAD 1-226961435-A-C, REVEL 0.54, CADD 24.50
- L18M (p.Leu18Met), gnomAD rs538203578, REVEL 0.37, CADD 24.20
- T19I (p.Thr19Ile), rs774521966, ClinGen CA1424914, ClinVar RCV002580166, ExAC rs774521966, REVEL 0.38, CADD 23.10, Likely benign, not provided
- T19N (p.Thr19Asn), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10082, REVEL 0.25, CADD 22.60, Variant assessed as somatic; moderate impact.
- T19S (p.Thr19Ser), ExAC rs774521966, TOPMed rs774521966, gnomAD rs774521966, REVEL 0.12, CADD 15.80, Likely benign
- T19T (p.Thr19Thr), rs769650823, gnomAD 1-226961442-C-G, CADD 8.25
- A21E (p.Ala21Glu), rs142184584, ClinGen CA345049564, ClinVar RCV003872899, REVEL 0.42, CADD 22.30, Uncertain significance, not provided
- A21P (p.Ala21Pro), ExAC rs750619418, gnomAD rs750619418, REVEL 0.48, CADD 26.20
- A21V (p.Ala21Val), rs142184584, ClinGen CA324324, cosmic curated COSV64659, ClinVar RCV000199769, REVEL 0.21, CADD 18.70, Conflicting interpretations, not specified; not provided
- A21R (p.Ala21Arg), gnomAD 1-226961444-AG-A, CADD 27.90
- A21T (p.Ala21Thr), gnomAD 1-226961446-G-A, REVEL 0.33, CADD 23.80
- A21A (p.Ala21Ala), rs11549709, gnomAD 1-226961448-G-A, CADD 3.35
- A22P (p.Ala22Pro), gnomAD rs1316238147, REVEL 0.34, CADD 22.60
- A22S (p.Ala22Ser), gnomAD 1-226961449-G-T, REVEL 0.12, CADD 20.90
- A22V (p.Ala22Val), gnomAD 1-226961450-C-T, REVEL 0.12, CADD 16.20
- A22A (p.Ala22Ala), rs753870775, gnomAD 1-226961451-C-T, CADD 4.74
- V23A (p.Val23Ala), rs778770085, ClinGen CA1424919, ClinVar RCV002711924, ExAC rs778770085, REVEL 0.20, CADD 22.40, Uncertain significance, not provided; Inborn genetic diseases
- V23L (p.Val23Leu), cosmic curated COSV10747
- V23M (p.Val23Met), rs35582308, ClinGen CA289296, ClinVar RCV000123533, ClinVar RCV000676176, REVEL 0.23, CADD 15.90, Conflicting interpretations, Inborn genetic diseases; not specified; not provided
- V23V (p.Val23Val), rs575567061, gnomAD 1-226961454-G-A, CADD 9.98
- E24K (p.Glu24Lys), cosmic curated COSV10528
- E24Q (p.Glu24Gln), 1000Genomes rs563890550, ExAC rs563890550, gnomAD rs563890550, REVEL 0.41, CADD 25.60
- T25I (p.Thr25Ile), gnomAD rs1223242512, REVEL 0.27, CADD 22.50
- T25P (p.Thr25Pro), gnomAD 1-226961458-A-C, REVEL 0.42, CADD 23.60
- T25T (p.Thr25Thr), rs1658248051, gnomAD 1-226961460-C-A, CADD 8.43
- H26R (p.His26Arg), gnomAD 1-226961462-A-G, REVEL 0.24, CADD 23.00
- H26H (p.His26His), rs150541057, gnomAD 1-226961463-C-T, CADD 7.30
- L27V (p.Leu27Val), gnomAD 1-226961464-C-G, REVEL 0.27, CADD 15.90
- L27P (p.Leu27Pro), gnomAD 1-226961465-T-C, REVEL 0.53, CADD 24.30
- Q28* (p.Gln28Ter), cosmic curated COSV64659, CADD 39.00
- Q28H (p.Gln28His), gnomAD 1-226961469-G-T, REVEL 0.28, CADD 22.30
- Q28Q (p.Gln28Gln), gnomAD 1-226961469-G-A, CADD 8.62
- H29Q (p.His29Gln), rs2528231325, ClinGen CA345049616, ClinVar RCV003036982, REVEL 0.10, CADD 15.00, Uncertain significance, not provided
- H29Y (p.His29Tyr), gnomAD 1-226961470-C-T, REVEL 0.11, CADD 14.10
- L30L (p.Leu30Leu), rs1331770829, gnomAD 1-226961473-T-C, CADD 6.08
- G31D (p.Gly31Asp), gnomAD 1-226961477-G-A, REVEL 0.32, CADD 22.00
- G31G (p.Gly31Gly), gnomAD 1-226961478-C-T, CADD 10.30
- I32V (p.Ile32Val), ExAC rs777619147, TOPMed rs777619147, gnomAD rs777619147, REVEL 0.07, CADD 13.70
- I32I (p.Ile32Ile), rs199919057, gnomAD 1-226961481-C-T, CADD 1.59
- G33R (p.Gly33Arg), rs552784842, ClinGen CA321854, ClinVar RCV000197396, ClinVar RCV005055708, REVEL 0.51, CADD 21.10, Uncertain significance, not specified; not provided
- G33* (p.Gly33Ter), gnomAD 1-226961482-G-T, CADD 35.00
- G34R (p.Gly34Arg), ESP rs142125927, ExAC rs142125927, TOPMed rs142125927, gnomAD rs142125927, REVEL 0.27, CADD 24.90
- G34G (p.Gly34Gly), rs1199101460, gnomAD 1-226961487-G-A, CADD 10.60
- E35* (p.Glu35Ter), ExAC rs749815821, gnomAD rs749815821, CADD 40.00
- E35V (p.Glu35Val), ExAC rs768978438, gnomAD rs768978438, REVEL 0.42, CADD 23.90
- E35E (p.Glu35Glu), gnomAD 1-226961490-G-A, CADD 9.00
- L36V (p.Leu36Val), ExAC rs774811481, gnomAD rs774811481, REVEL 0.11, CADD 18.00
- L36L (p.Leu36Leu), rs774811481, gnomAD 1-226961491-C-T, CADD 9.86
- I37S (p.Ile37Ser), Ensembl rs1658250494
- I37I (p.Ile37Ile), gnomAD 1-226961496-C-T, CADD 6.77
- M38I (p.Met38Ile), ESP rs369961952, ExAC rs369961952, TOPMed rs369961952, gnomAD rs369961952, REVEL 0.14, CADD 16.70
- M38L (p.Met38Leu), ExAC rs762117943, gnomAD rs762117943, REVEL 0.08, CADD 0.04
- M38V (p.Met38Val), gnomAD 1-226961497-A-G, REVEL 0.02, CADD 0.02
- A39E (p.Ala39Glu), cosmic curated COSV64659
- A39V (p.Ala39Val), rs773489358, ClinGen CA1424929, NCI-TCGA Cosmic COSV6465, ClinVar RCV001095969, REVEL 0.08, CADD 10.70, Uncertain significance, not provided; Autosomal recessive ataxia due to ubiquinone deficiency
- A39A (p.Ala39Ala), rs11549708, gnomAD 1-226961502-G-A, CADD 3.92
- A40G (p.Ala40Gly), Ensembl rs2148051948
- A42T (p.Ala42Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A42S (p.Ala42Ser), gnomAD 1-226961509-G-T, REVEL 0.12, CADD 13.80
- A42V (p.Ala42Val), gnomAD 1-226961510-C-T, REVEL 0.09, CADD 20.00
- A42A (p.Ala42Ala), gnomAD 1-226961511-C-G, CADD 10.60
- L43M (p.Leu43Met), ExAC rs753789581, gnomAD rs753789581
- L43Q (p.Leu43Gln), ExAC rs754971776, TOPMed rs754971776, gnomAD rs754971776, REVEL 0.47, CADD 25.30
- L43C (p.Leu43Cys), rs754586499, gnomAD 1-226961509-GC-G, CADD 26.20
- L43L (p.Leu43Leu), rs753789581, gnomAD 1-226961512-C-T, CADD 9.06
- L43P (p.Leu43Pro), gnomAD 1-226961513-T-C, REVEL 0.44, CADD 23.90
- Q44K (p.Gln44Lys), cosmic curated COSV10820, REVEL 0.29, CADD 23.80
- Q44* (p.Gln44Ter), gnomAD 1-226961515-C-T, CADD 38.00
- Q44H (p.Gln44His), gnomAD 1-226961517-G-T, REVEL 0.34, CADD 25.80
- S45F (p.Ser45Phe), gnomAD rs1252513816, REVEL 0.20, CADD 23.50
- S45P (p.Ser45Pro), TOPMed rs1347944525, gnomAD rs1347944525, REVEL 0.08, CADD 23.50
- T46A (p.Thr46Ala), ExAC rs765033818, gnomAD rs765033818, REVEL 0.08, CADD 17.10
- T46K (p.Thr46Lys), 1000Genomes rs187123516, ExAC rs187123516, TOPMed rs187123516, gnomAD rs187123516, REVEL 0.24, CADD 22.20, Uncertain significance
- T46M (p.Thr46Met), rs187123516, ClinGen CA1424935, cosmic curated COSV10082, ClinVar RCV001932862, REVEL 0.24, CADD 23.50, Uncertain significance, not provided
- T46P (p.Thr46Pro), gnomAD 1-226961521-A-C, REVEL 0.31, CADD 22.80
- T46T (p.Thr46Thr), rs1404709843, gnomAD 1-226961523-G-A, CADD 1.63
- A47G (p.Ala47Gly), TOPMed rs1348574417
- A47T (p.Ala47Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A47A (p.Ala47Ala), rs1658254343, gnomAD 1-226961526-T-C, CADD 2.91
- V48M (p.Val48Met), TOPMed rs1320503257
- E49K (p.Glu49Lys), rs372935246, ClinGen CA1424936, ClinVar RCV002632223, ESP rs372935246, REVEL 0.29, CADD 23.40, Uncertain significance, not provided
- E49Q (p.Glu49Gln), NCI-TCGA Cosmic COSV6465, cosmic curated COSV64658, Variant assessed as somatic; moderate impact.
- Q50H (p.Gln50His), rs2148052080, ClinGen CA345049741, ClinVar RCV001663626, Ensembl rs2148052080, REVEL 0.27, CADD 21.00, Uncertain significance, not provided
- I51T (p.Ile51Thr), TOPMed rs909089215, gnomAD rs909089215, REVEL 0.18, CADD 22.80
- G52D (p.Gly52Asp), gnomAD rs1349356298, REVEL 0.19, CADD 7.00
- G52G (p.Gly52Gly), gnomAD 1-226961541-C-T, CADD 5.41
- M53I (p.Met53Ile), ExAC rs777709068, gnomAD rs777709068
- M53L (p.Met53Leu), TOPMed rs1209872503, gnomAD rs1209872503
- M53V (p.Met53Val), TOPMed rs1209872503, gnomAD rs1209872503
- F54V (p.Phe54Val), gnomAD 1-226961545-T-G, REVEL 0.15, CADD 8.48
- F54L (p.Phe54Leu), gnomAD 1-226961547-C-G, REVEL 0.07, CADD 9.65
- L55M (p.Leu55Met), cosmic curated COSV10747
- L55L (p.Leu55Leu), gnomAD 1-226961550-G-A, CADD 0.92
- G56V (p.Gly56Val), cosmic curated COSV10082
- G56W (p.Gly56Trp), cosmic curated COSV99067
- G56R (p.Gly56Arg), gnomAD 1-226961551-G-A, REVEL 0.30, CADD 23.10
- G56G (p.Gly56Gly), rs942056497, gnomAD 1-226961553-G-A, CADD 4.53
- K57E (p.Lys57Glu), rs746720374, ClinGen CA1424938, ClinVar RCV003039143, ExAC rs746720374, REVEL 0.07, CADD 11.10, Uncertain significance, not provided
- K57N (p.Lys57Asn), 1000Genomes rs200123840, ExAC rs200123840, gnomAD rs200123840, REVEL 0.06, CADD 6.28
- V58G (p.Val58Gly), Ensembl rs1572040500
- V58L (p.Val58Leu), gnomAD rs867953424
- V58M (p.Val58Met), gnomAD rs867953424
- V58V (p.Val58Val), gnomAD 1-226961559-G-A, CADD 0.51
- Q59* (p.Gln59Ter), rs1572040505, ClinGen CA345049797, ClinVar RCV000995683, Ensembl rs1572040505, CADD 41.00, Pathogenic
- Q59L (p.Gln59Leu), gnomAD 1-226961561-A-T, REVEL 0.34, CADD 23.30
- G60D (p.Gly60Asp), TOPMed rs754837883, gnomAD rs754837883, REVEL 0.11, CADD 18.80
- G60R (p.Gly60Arg), ESP rs369252071, ExAC rs369252071, TOPMed rs369252071, gnomAD rs369252071, REVEL 0.22, CADD 23.90, Uncertain significance
- G60S (p.Gly60Ser), rs369252071, ClinGen CA1424958, ClinVar RCV001976393, ESP rs369252071, REVEL 0.18, CADD 23.20, Uncertain significance, not provided
- G60V (p.Gly60Val), gnomAD 1-226965001-G-T, REVEL 0.27, CADD 20.60
- G60G (p.Gly60Gly), rs1658471458, gnomAD 1-226965002-T-A, CADD 14.90
- Q61P (p.Gln61Pro), ExAC rs755645245, gnomAD rs755645245, REVEL 0.15, CADD 20.90
- D62V (p.Asp62Val), NCI-TCGA Cosmic COSV6465, cosmic curated COSV64658, Variant assessed as somatic; moderate impact.
- K63N (p.Lys63Asn), gnomAD rs1297904224, REVEL 0.05, CADD 14.40
- K63G (p.Lys63Gly), gnomAD 1-226965008-T-TGG, CADD 24.30
- H64Q (p.His64Gln), TOPMed rs1572045723, gnomAD rs1572045723, REVEL 0.16, CADD 0.25, Likely benign
- H64Y (p.His64Tyr), Ensembl rs1558190673, REVEL 0.16, CADD 8.90
- H64R (p.His64Arg), gnomAD 1-226965013-A-G, REVEL 0.10, CADD 0.00
- H64H (p.His64His), rs1572045723, gnomAD 1-226965014-T-C, CADD 0.64
- E65D (p.Glu65Asp), cosmic curated COSV10468
- E66K (p.Glu66Lys), cosmic curated COSV64658
- E66A (p.Glu66Ala), gnomAD 1-226965019-A-C, REVEL 0.12, CADD 14.60
- Y67Y (p.Tyr67Tyr), gnomAD 1-226965023-T-C, CADD 0.09
- F68C (p.Phe68Cys), TOPMed rs961234026
- F68I (p.Phe68Ile), gnomAD rs1434538212, REVEL 0.05, CADD 7.80
- F68L (p.Phe68Leu), gnomAD 1-226965026-T-G, REVEL 0.07, CADD 1.66
- A69D (p.Ala69Asp), rs1169606390, NCI-TCGA Cosmic COSV6465, cosmic curated COSV64656, TOPMed rs1169606390, REVEL 0.11, CADD 0.22, Variant assessed as somatic; moderate impact.
- A69S (p.Ala69Ser), gnomAD rs1403611525, REVEL 0.12, CADD 0.18
- A69A (p.Ala69Ala), gnomAD 1-226965029-T-C, CADD 0.15
- E70G (p.Glu70Gly), cosmic curated COSV10889
- E70* (p.Glu70Ter), gnomAD 1-226965030-G-T, CADD 36.00
- N71K (p.Asn71Lys), TOPMed rs1658473093
- N71Y (p.Asn71Tyr), rs779601942, ClinGen CA1424962, ClinVar RCV001904534, ExAC rs779601942, REVEL 0.10, CADD 12.50, Uncertain significance, not provided
- N71T (p.Asn71Thr), rs752417487, gnomAD 1-226965031-AG-A, CADD 25.10
- N71H (p.Asn71His), gnomAD 1-226965033-A-C, REVEL 0.06, CADD 10.00
- N71N (p.Asn71Asn), rs1658473093, gnomAD 1-226965035-C-T, CADD 3.31
- F72F (p.Phe72Phe), rs372825175, gnomAD 1-226965038-C-T, CADD 0.11
- G73D (p.Gly73Asp), Ensembl rs2148061481
- G73S (p.Gly73Ser), rs1244551709, NCI-TCGA Cosmic COSV9906, cosmic curated COSV99067, TOPMed rs1244551709, REVEL 0.17, CADD 16.50, Variant assessed as somatic; moderate impact.
- G73G (p.Gly73Gly), rs377201559, gnomAD 1-226965041-C-T, CADD 0.03
- G74C (p.Gly74Cys), TOPMed rs778948697, gnomAD rs778948697, REVEL 0.18, CADD 20.90, Uncertain significance
- G74D (p.Gly74Asp), NCI-TCGA Cosmic COSV6465, cosmic curated COSV64657, REVEL 0.15, CADD 6.08, Variant assessed as somatic; moderate impact.
- G74R (p.Gly74Arg), TOPMed rs778948697, gnomAD rs778948697, REVEL 0.14, CADD 13.80, Uncertain significance
Public COQ8A analysis runs
- COQ8A analysis run — COQ8A (1,263 variants) — completed 2026-08-20